Acetyl-d-carnitine

Acetyl-d-carnitine is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 2875 references associated with Acetyl-d-carnitine in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for Acetyl-d-carnitine

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Acetyl-d-carnitine

MeSH term MeSH ID Detail
Proteostasis Deficiencies D057165 5 associated lipids
Cleft Lip D002971 8 associated lipids
Amino Acid Metabolism, Inborn Errors D000592 16 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Parkinson Disease D010300 53 associated lipids
Alzheimer Disease D000544 76 associated lipids
Body Weight D001835 333 associated lipids
Total 7

All references with Acetyl-d-carnitine

Download all related citations
Per page 10 20 50 100 | Total 877
Authors Title Published Journal PubMed Link
Cheng KH et al. Newborn screening for methylmalonic aciduria by tandem mass spectrometry: 7 years' experience from two centers in Taiwan. 2010 J Chin Med Assoc pmid:20603089
Binienda ZK et al. Assessment of 3-nitropropionic acid-evoked peripheral neuropathy in rats: neuroprotective effects of acetyl-l-carnitine and resveratrol. 2010 Neurosci. Lett. pmid:20542088
Rump TJ et al. Acetyl-L-carnitine protects neuronal function from alcohol-induced oxidative damage in the brain. 2010 Free Radic. Biol. Med. pmid:20708681
Kuritzky L Managing diabetic peripheral neuropathic pain in primary care. 2010 J Fam Pract pmid:20544053
Lancaster CS et al. Cisplatin-induced downregulation of OCTN2 affects carnitine wasting. 2010 Clin. Cancer Res. pmid:20858838
Pisano C et al. Metabolic approach to the enhancement of antitumor effect of chemotherapy: a key role of acetyl-L-carnitine. 2010 Clin. Cancer Res. pmid:20562210
Palermo V et al. Acetyl-L-carnitine protects yeast cells from apoptosis and aging and inhibits mitochondrial fission. 2010 Aging Cell pmid:20550520
Hori T et al. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation. 2010 Tohoku J. Exp. Med. pmid:20543534
Scafidi S et al. Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain. 2010 J. Neurochem. pmid:20477950
Ruggenenti P et al. Oral acetyl-L-carnitine therapy and insulin resistance. 2010 Hypertension pmid:20439816

Table of Content